ID 6ACRA STANDARD; PRT; 301 AA. DT CONVERTED FROM PDB (SEQRES) 6ACR DE Activin receptor type-1 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.010 CC R-Factor 0.215 FT #SUB 123 321 ILE A 126 324 PHE B Protein S 4 FT #SUB 126 324 PHE A 123 321 ILE B Protein S 2 FT #SUB 126 324 PHE A 291 489 LEU B Protein S 2 FT #SUB 165 363 GLN A 289 487 THR B Protein B 1 FT #SUB 166 364 SER A 289 487 THR B Protein B 5 FT #SUB 166 364 SER A 291 489 LEU B Protein S 1 FT #SUB 166 364 SER A 292 490 ARG B Protein B 1 FT #SUB 166 364 SER A 295 493 LYS B Protein S 1 FT #SUB 168 366 ASN A 203 401 ARG B Protein S 1 FT #SUB 202 400 LYS A 165 363 GLN B Protein S 3 FT #SUB 289 487 THR A 165 363 GLN B Protein S 3 FT #SUB 289 487 THR A 166 364 SER B Protein S 5 FT #SUB 289 487 THR A 168 366 ASN B Protein S 2 FT #SUB 291 489 LEU A 126 324 PHE B Protein S 3 FT #SUB 291 489 LEU A 166 364 SER B Protein S 3 FT #SUB 292 490 ARG A 166 364 SER B Protein S 1 FT #HET 16 214 VAL A 1 501 9TO A A 8 FT #HET 24 222 VAL A 1 501 9TO A S 1 FT #HET 35 233 ALA A 1 501 9TO A S 4 FT #HET 37 235 LYS A 1 501 9TO A S 3 FT #HET 62 260 GLU A 3 503 SO4 A B 1 FT #HET 64 262 ILE A 3 503 SO4 A B 2 FT #HET 65 263 LEU A 1 501 9TO A S 3 FT #HET 65 263 LEU A 3 503 SO4 A A 3 FT #HET 66 264 GLY A 3 503 SO4 A B 5 FT #HET 83 281 LEU A 1 501 9TO A S 2 FT #HET 85 283 THR A 1 501 9TO A S 6 FT #HET 86 284 HIS A 1 501 9TO A B 1 FT #HET 86 284 HIS A 3 503 SO4 A S 8 FT #HET 87 285 TYR A 1 501 9TO A A 18 FT #HET 88 286 HIS A 1 501 9TO A B 9 FT #HET 88 286 HIS A 2 502 SO4 A A 8 FT #HET 88 286 HIS A 3 503 SO4 A S 7 FT #HET 91 289 GLY A 1 501 9TO A B 2 FT #HET 95 293 ASP A 1 501 9TO A S 1 FT #HET 142 340 LYS A 1 501 9TO A B 1 FT #HET 145 343 LEU A 1 501 9TO A S 9 FT #HET 147 345 LYS A 2 502 SO4 A B 1 FT #HET 147 345 LYS A 3 503 SO4 A S 1 FT #HET 148 346 LYS A 2 502 SO4 A A 6 FT #HET 153 351 CYS A 3 503 SO4 A S 1 FT #HET 182 380 ARG A 4 504 SO4 A S 10 FT #HET 239 437 ASN A 4 504 SO4 A B 2 FT #HET 240 438 ASP A 4 504 SO4 A A 7 FT #HET 241 439 PRO A 4 504 SO4 A S 3 FT DISORDER 1 4 FT DISORDER 128 129 FT DISORDER 301 301 CC SEQUENCE 294 AA (ATOM); CC TVAHQITLLE CVGKGRYGEV WRGSWQGENV AVKIFSSRDE KSWFRETELY NTVMLRHENI CC LGFIASDMTS RHSSTQLWLI THYHEMGSLY DYLQLTTLDT VSCLRIVLSI ASGLAHLHIE CC IFGGKPAIAH RDLKSKNILV KKNGQCCIAD LGLAVMHSQS TNQLDVGNNP RVGTKRYMAP CC EVLDETIQVD CFDSYKRVDI WAFGLVLWEV ARRMVSNGIV EDYKPPFYDV VPNDPSFEDM CC RKVVCVDQQR PNIPNRWFSD PTLTSLAKLM KECWYQNPSA RLTALRIKKT LTKI CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES SMQRTVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE CC ATOM ----TVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE CC ********************************************** CC SEQRES TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT CC ATOM TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT CC ************************************************** CC SEQRES TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG CC ATOM TLDTVSCLRIVLSIASGLAHLHIEIFG--GKPAIAHRDLKSKNILVKKNG CC *************************** ********************* CC SEQRES QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS CC ATOM QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS CC ************************************************** CC SEQRES YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV CC ATOM YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV CC ************************************************** CC SEQRES CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI CC ATOM CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI CC ************************************************** CC SEQRES D CC ATOM - CC SQ SEQUENCE 301 AA; MW; CN; SMQRTVAHQI TLLECVGKGR YGEVWRGSWQ GENVAVKIFS SRDEKSWFRE TELYNTVMLR HENILGFIAS DMTSRHSSTQ LWLITHYHEM GSLYDYLQLT TLDTVSCLRI VLSIASGLAH LHIEIFGTQG KPAIAHRDLK SKNILVKKNG QCCIADLGLA VMHSQSTNQL DVGNNPRVGT KRYMAPEVLD ETIQVDCFDS YKRVDIWAFG LVLWEVARRM VSNGIVEDYK PPFYDVVPND PSFEDMRKVV CVDQQRPNIP NRWFSDPTLT SLAKLMKECW YQNPSARLTA LRIKKTLTKI D // ID 6ACRB STANDARD; PRT; 301 AA. DT CONVERTED FROM PDB (SEQRES) 6ACR DE Activin receptor type-1 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.010 CC R-Factor 0.215 FT #SUB 123 321 ILE B 126 324 PHE A Protein S 2 FT #SUB 126 324 PHE B 123 321 ILE A Protein S 4 FT #SUB 126 324 PHE B 291 489 LEU A Protein S 3 FT #SUB 165 363 GLN B 202 400 LYS A Protein S 3 FT #SUB 165 363 GLN B 289 487 THR A Protein B 3 FT #SUB 166 364 SER B 289 487 THR A Protein B 5 FT #SUB 166 364 SER B 291 489 LEU A Protein S 3 FT #SUB 166 364 SER B 292 490 ARG A Protein B 1 FT #SUB 168 366 ASN B 289 487 THR A Protein S 2 FT #SUB 203 401 ARG B 168 366 ASN A Protein S 1 FT #SUB 289 487 THR B 165 363 GLN A Protein S 1 FT #SUB 289 487 THR B 166 364 SER A Protein S 5 FT #SUB 291 489 LEU B 126 324 PHE A Protein S 2 FT #SUB 291 489 LEU B 166 364 SER A Protein S 1 FT #SUB 292 490 ARG B 166 364 SER A Protein S 1 FT #SUB 295 493 LYS B 166 364 SER A Protein S 1 FT #HET 16 214 VAL B 5 501 9TO B A 10 FT #HET 24 222 VAL B 5 501 9TO B S 1 FT #HET 35 233 ALA B 5 501 9TO B S 3 FT #HET 37 235 LYS B 5 501 9TO B S 3 FT #HET 62 260 GLU B 8 504 SO4 B B 1 FT #HET 64 262 ILE B 8 504 SO4 B B 2 FT #HET 65 263 LEU B 5 501 9TO B S 3 FT #HET 65 263 LEU B 8 504 SO4 B A 3 FT #HET 66 264 GLY B 8 504 SO4 B B 5 FT #HET 83 281 LEU B 5 501 9TO B A 3 FT #HET 85 283 THR B 5 501 9TO B S 5 FT #HET 86 284 HIS B 5 501 9TO B B 1 FT #HET 86 284 HIS B 8 504 SO4 B S 6 FT #HET 87 285 TYR B 5 501 9TO B A 8 FT #HET 88 286 HIS B 5 501 9TO B A 12 FT #HET 88 286 HIS B 7 503 SO4 B A 8 FT #HET 88 286 HIS B 8 504 SO4 B S 7 FT #HET 89 287 GLU B 5 501 9TO B B 2 FT #HET 91 289 GLY B 5 501 9TO B B 3 FT #HET 95 293 ASP B 5 501 9TO B S 2 FT #HET 145 343 LEU B 5 501 9TO B S 8 FT #HET 147 345 LYS B 7 503 SO4 B A 5 FT #HET 147 345 LYS B 8 504 SO4 B S 2 FT #HET 148 346 LYS B 7 503 SO4 B A 7 FT #HET 153 351 CYS B 8 504 SO4 B S 2 FT #HET 182 380 ARG B 6 502 SO4 B S 10 FT #HET 239 437 ASN B 6 502 SO4 B B 2 FT #HET 240 438 ASP B 6 502 SO4 B B 5 FT #HET 241 439 PRO B 6 502 SO4 B S 4 FT DISORDER 1 4 FT DISORDER 127 129 FT DISORDER 301 301 CC SEQUENCE 293 AA (ATOM); CC TVAHQITLLE CVGKGRYGEV WRGSWQGENV AVKIFSSRDE KSWFRETELY NTVMLRHENI CC LGFIASDMTS RHSSTQLWLI THYHEMGSLY DYLQLTTLDT VSCLRIVLSI ASGLAHLHIE CC IFGKPAIAHR DLKSKNILVK KNGQCCIADL GLAVMHSQST NQLDVGNNPR VGTKRYMAPE CC VLDETIQVDC FDSYKRVDIW AFGLVLWEVA RRMVSNGIVE DYKPPFYDVV PNDPSFEDMR CC KVVCVDQQRP NIPNRWFSDP TLTSLAKLMK ECWYQNPSAR LTALRIKKTL TKI CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES SMQRTVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE CC ATOM ----TVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE CC ********************************************** CC SEQRES TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT CC ATOM TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT CC ************************************************** CC SEQRES TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG CC ATOM TLDTVSCLRIVLSIASGLAHLHIEIF---GKPAIAHRDLKSKNILVKKNG CC ************************** ********************* CC SEQRES QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS CC ATOM QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS CC ************************************************** CC SEQRES YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV CC ATOM YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV CC ************************************************** CC SEQRES CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI CC ATOM CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI CC ************************************************** CC SEQRES D CC ATOM - CC SQ SEQUENCE 301 AA; MW; CN; SMQRTVAHQI TLLECVGKGR YGEVWRGSWQ GENVAVKIFS SRDEKSWFRE TELYNTVMLR HENILGFIAS DMTSRHSSTQ LWLITHYHEM GSLYDYLQLT TLDTVSCLRI VLSIASGLAH LHIEIFGTQG KPAIAHRDLK SKNILVKKNG QCCIADLGLA VMHSQSTNQL DVGNNPRVGT KRYMAPEVLD ETIQVDCFDS YKRVDIWAFG LVLWEVARRM VSNGIVEDYK PPFYDVVPND PSFEDMRKVV CVDQQRPNIP NRWFSDPTLT SLAKLMKECW YQNPSARLTA LRIKKTLTKI D //